MBIO - Mustang Bio Inc
IEX Last Trade
0.2735
-0.029 -10.640%
Share volume: 1,577,133
Last Updated: Fri 30 Aug 2024 08:26:21 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.30
-0.03
-9.62%
Summary score
19%
Profitability
8%
Dept financing
6%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.13%
Return on assets
-15.56%
Return on sales
23800%
Return on invested capital
-392.68%
Total debt ratio
20.06%
Debt ratio change over timeo
-1.01%
Current Ratio
15.66%
Quick Ratio
0%
Cash Position Ratio
13.43%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.53%
Return on assets
-16.25%
Return on sales
0%
Return on invested capital
-509.17%
Total debt ratio
28.76%
Debt ratio change over timeo
-1.06%
Current Ratio
7.88%
Quick Ratio
0%
Cash Position Ratio
7.7%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-20.55%
Return on assets
-14.58%
Return on sales
0%
Return on invested capital
348.07%
Total debt ratio
26.65%
Debt ratio change over time
-1.02%
Current Ratio
5.85%
Quick Ratio
0%
Cash Position Ratio
5.79%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.08%
Return on assets
-103.52%
Return on sales
-11607.45%
Return on invested capital
45.9%
Total debt ratio
-100.64%
Debt ratio change over time
-1.01%
Current Ratio
3.49%
Quick Ratio
0%
Cash Position Ratio
1.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | MBIO | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -22.13% | -3.05% | 11.55% | 6.27% |
Return on assets | -15.56% | 3.6% | 3.57% | 5.27% |
Return on sales | 23800% | 32.14% | 42.16% | 33.08% |
Return on invested capital | -392.68% | 5.09% | 7.99% | 13.19% |
Profitability | 25% | 27% | 57% | 64% |
Total debt ratio | 20.06% | 101.18% | 74.11% | 29.58% |
Debt ratio change over time | -1.01% | 6.09% | 6.03% | 1.53% |
Dept financing | 5% | 50% | 43% | 14% |
Current Ratio | 7.88% | 2.08% | 2.02% | 3.51% |
Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
Cash Position Ratio | 7.7% | 1.48% | 0.76% | 1.49% |
Liquididy | 50% | 14% | 32% | 31% |
Short-term ratios | MBIO | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -23.53% | -25.62% | 17.94% | 7.14% |
Return on assets | -16.25% | 3.26% | 3.67% | 4.71% |
Return on sales | 0% | 31.22% | 37.5% | 33.58% |
Return on invested capital | -509.17% | 8.14% | 7.17% | 18.16% |
Profitability | 0% | 49% | 79% | 82% |
Total debt ratio | 28.76% | 105.33% | 83.42% | 27.49% |
Debt ratio change over time | -1.06% | -23.44% | 9.66% | 0.6% |
Dept financing | 7% | 25% | 45% | 8% |
Current Ratio | 7.88% | 2.08% | 2.02% | 3.51% |
Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
Cash Position Ratio | 7.7% | 1.48% | 0.76% | 1.49% |
Liquididy | 50% | 29% | 24% | 41% |